1230
Helvetica Chimica Acta Vol. 86 (2003)
1,3,5,7-Tetramethyl-1-azoniatricyclo[3.3.1.13,7]decan-2-olate (2). Procedure A. The amino alcohol 9 [11]
(0.759 g, 3.6 mmol) was dissolved in acetone (30 ml) and Jones× reagent (prepared from 0.901 g of CrO3, 0.85 ml
of H2SO4 and 1.7 ml of H2O) was added. The mixture was stirred for 2 h at r.t., then H2O (75 ml) was added,
followed by i-PrOH (20 ml) to destroy excess oxidant. After stirring for a further 0.5 h, a sat. soln. of Na2CO3
was added (care!) to bring the pH to ca. 9. The resulting mixture was evaporated, and the product was sublimed
(808, 0.05 mm) from the remained solid, then resublimed to give crystalline 2 (0.585 g, 77.9%).
Procedure B. To a suspension of the amino acid 10 [11] (0.1 mmol), LiAlH4 (0.6 mmol) was added carefully,
and the mixture was refluxed under Ar for 2 h. H2O was added to quench the excess reducing agent, the product
was extracted with CH2Cl2, the extract was dried over 3 g of K2CO3, evaporated without filtration, and the dry
product was sublimed to give crystalline 2, as before; 0.585 g (77 % yield).
Procedure C (not described), starting from the amino alcohol 11 [11], gave an identical product, M.p. 638.
Data of 2. IR: 2956, 2200, 1459, 1216. 1H-NMR (400 MHz, CDCl3) d: 6.61 (s, HÀC(2)); 2.74( d, J 10.83,
HÀC(8), HÀC(8a)); 2.23 (s, MeN); 2.08 (dd, J 10.83, 2.45, HeqÀC(8), HeqÀC(9)); 1.86 (dd, J 12.6, 2.45,
HeqÀC(4), HeqÀC(10)); 1.17 (dt, J 11.8, 2.45, HeqÀC(6)); 1.095 (dt, J 11.8, 2.45, HaxÀC(6)); 1.025 (dd, J
12.6, 2.45, HaxÀC(4), HaxÀC(10)); 0.86 (s, MeÀC(5), MeÀC(7)); 0.85 (s, MeÀC(3) (assigned from COSY,
HMQC, HMBC). 13C-NMR (100.59 MHz, CDCl3): 130.0; 63.58; 47.46; 46.41; 44.29; 39.89; 31.07; 26.57; 26.32.
EI-MS: 209 (4%, M ) 208 (13%, [M À H] ), 181 (68%, [M À CO] ), 180 (51%, [M À H À CO] ), 58 (100,
C3H5N ). FAB-MS (positive): 419 (18, [2M H] ), 210 (100, [M H] ), 93 (8), 58 (6). HR-FAB-MS:
210.18590 (C13H23NO H; calc. 210.18578).
1H-NMR Spectra of a triply-sublimed sample, taken in carefully dried solvents, showed additional peaks
assigned to H2O: a br. s (4.33 ppm) in CD2Cl2 and a s (1.56 ppm) in C6D6), which careful integration showed to
be equivalent to 0.5 H2O. Microanalysis was consistent with this conclusion: calc. for the hemihydrate:
C13H23NO ¥ 0.5 H2O: C 71.51, H 11.08, N 6.42; found: C 71.91, H 11.08, N 6.42. The compound prepared by
Procedure A had essentially the same spectral data, except that no H2O peak is visible in the 1H-NMR taken in
CD2Cl2, and the analysis is most consistent with an anhydrous product: calc. for C13H23NO: C 74.59, H 11.02,
N 6.69; found: C 73.55, H 11.07, N 6.64.
2-Methoxy-1,3,5,7-tetramethyl-1-azoniatricyclo[3.3.1.13,7]decane Tetrafluoroborate (2 ¥ Me). The methyla-
tion of the nominally alkoxide O-atom of 2 needed Meerwein×s reagent. The reaction was carried out in a flame-
dried flask under Ar. Compound 2 (50 mg, 0.24mmol) and trimethyloxonium tetrafluoroborate (42.4mg,
0.29 mmol), were placed in the reaction flask, and dry CH2Cl2 (2 ml) was added. The mixture was stirred at r.t.
for 1 h, then a new portion of the alkylating agent (10 mg, 0.07 mmol) was added. The mixture was stirred
overnight, then treated with MeOH (5 ml). All volatile products were evaporated, and the solid residue was
dissolved in CH2Cl2 (0.5 ml) and filtered. The product was precipitated from the filtrate soln. with Et2O, filtered,
and dried under vacuum to give crystals of 2 ¥ Me (59.9 mg, 80.6%). M.p. 161 1628. 1H-NMR (400 MHz,
CDCl3): 4.47 (s, HÀC(2)); 3.75 (s, MeO); 3.50 (d, J 12.3, HeqÀC(9)); 3.13 (d, J 12.3, HaxÀC(9)); 3.12 (d, J
12.3, HeqÀC(8)); 2.99 (s, MeN); 2.80 (d, J 12.3, HaxÀC(8)); 1.78 (d, J 13.4, HeqÀC(6)); 1.64( d, J 13.09,
HeqÀC(10)); 1.49 (d, J 13.4, HeqÀC(4)); 1.26 (d d, J 13.4, HaxÀC(4), HaxÀC(6)); 1.01 (d, J 13.09,
HaxÀC(10)); 0.99 (s, MeÀC(3)); 0.94( s, Me); 0.93 (s, Me) (assigned from COSY, HMBC, HMQC). 13C-NMR
(100.59 MHz, CDCl3): 101.46 (C(2)); 68.4 (C(9)); 63.5 (MeO); 61.9 (C(8)); 49.1 (MeN); 46.35 (C(6)); 45.70
(C(4)); 40.32 (C(10)); 36.45 (C(3)); 30.82 (C(5), C(7)); 25.55 (Me); 24.79 (Me); 23.73 (Me) (assigned from
APT, HMBC, HMQC).
The preparation of the homologues of 2 lacking two or all three ring MeÀC groups, required a different
approach [15]. These systems (6 > 7, R Me and H) were synthesized as outlined in Scheme 2. (There is a
possibility of racemization of 14 during its hydrolysis to 16. None was observed; the tricyclic product 17 was
formed in high yield.)
Ethyl 3-Benzoyl-7-methyl-3-azabicyclo[3.3.1]nonane-7-carboxylate (15). A soln. of BuLi (17.6 ml of 1.6m
(ca. 15%) in hexanes) was added to a soln. of i-Pr2NH (3.67 ml in 200 ml of Et2O) at 08 (ice-water bath). After
stirring at 08 for ca. 1 h, a soln. of 14 [14] (3.9 g in 100 ml of Et2O) was added dropwise, the ice bath was
removed, and the soln. was stirred for a further 2 h at r.t. Freshly distilled Me2SO4 (2.65 ml) was carefully added
to the stirred mixture. The reaction was exothermic, and a white precipitate formed immediately. Stirring was
continued overnight, then the precipitate was filtered off. The filtrate was washed with H2O, 5% NH3 and 1n
HCl, brine, then dried (MgSO4) and evaporated. The colourless viscous oil obtained (3.4g, 85% yield) was
subjected to acid hydrolysis (aq. HBr) without further purification. The product could be purified by column
chromatography (SiO2; AcOEt/hexane 1:1): crystals. Rf 0.34(SiO 2; AcOEt/hexane, 1:1). IR (CDCl3): 2912,
2857 (CH); 1710 (CO); 1621 (CO); 1453 (Ph); 1416. 1H-NMR (CDCl3, 500 MHz): 7.48 (dd, J 7.0, 1.7,
2 Ho); 7.36 (m, 2 Hm, 1 Hp); 4.47 (d, J 13.7); 4.23 (dq, J 7.07, 3.42, 1 H, MeCH2); 4.13 (dq, J 7.07, 3.42, 1 H,